首页 › 基金 › ORBIMED ADVISORS LLC › CAI

ORBIMED ADVISORS LLC 对 CAI 的持仓历史

CARIS LIFE SCIENCES INC · 医疗保健

ORBIMED ADVISORS LLC 在 Q2 2026 的 13F 申报中披露持有 CAI(CARIS LIFE SCIENCES INC)2,806,811 股,市值约 US$50.0M,约占其申报组合的 1.01%,在其申报持仓中市值排名第 32 位。 ORBIMED ADVISORS LLC 最近 5 个申报季度中有 5 个季度披露了 CAI 持仓,最早可追溯至 Q2 2025。

最新持仓 (Q2 2026)2.81M 股
申报持仓市值$50.02M
组合权重1.01%
首次申报Q2 2025
最近变动持有
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

ORBIMED ADVISORS LLC 对 CAI 的持仓演变

ORBIMED ADVISORS LLC 于 Q2 2025 首次披露 CAI 持仓:3,034,858 股(约 US$81.1M)。 该持仓在 Q3 2025 达到峰值 3,034,858 股,市值约 US$91.8M。 在 5 次申报中,ORBIMED ADVISORS LLC 1 次增持、1 次减持、2 次保持不变。 最近一期申报(Q2 2026)显示持股 2,806,811 股、市值约 US$50.0M。

逐季持仓明细

季度股数金额变化
Q2 2025 3.03M $81.09M 新进
Q3 2025 3.03M $91.80M 持有
Q4 2025 3.12M $84.07M 增持
Q1 2026 2.81M $50.19M 减持
Q2 2026 2.81M $50.02M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 CAI 与 13F 数据

CAI(CARIS LIFE SCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 CAI,申报仓位最大的包括:J. H. Whitney Equity Partners VI, LLC (US$200.6M), Coatue 管理 (US$175.0M), COATUE MANAGEMENT LLC (US$175.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CAI 的基金

查看 CAI 的全部基金持有人 →

常见问题

How long has ORBIMED ADVISORS LLC held CAI?

ORBIMED ADVISORS LLC has disclosed CAI holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is ORBIMED ADVISORS LLC's current position in CAI?

As of Q2 2026, ORBIMED ADVISORS LLC holds 2.81M shares of CAI (CARIS LIFE SCIENCES INC), valued at $50.02M, representing 1.01% of its reported portfolio and ranking #32.

Has ORBIMED ADVISORS LLC been buying or selling CAI?

In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC held unchanged its position in CAI. The position peaked in Q3 2025 at 3.03M shares.

Which other funds hold CAI?

Other major institutional holders of CAI include J. H. Whitney Equity Partners VI, LLC, Coatue 管理, COATUE MANAGEMENT LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.